Related Experiment Video
Updated: Nov 6, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
CircATRNL1 protects against osteoarthritis by targeting miR-153-3p and KLF5
Kai-Fu Wang1, Zuo-Wei Shi1, Da-Ming Dong1
1Department of Orthopaedics, the 1st Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Background:
Osteoarthritis (OA) is characterized by chondrocyte injury. Circular RNAs (circRNAs) are involved in the pathogenesis of various diseases, including OA. The purpose of this study was to determine the potential role of circATRNL1 in OA pathology in vitro.
Methods:
Human chondrocytes were isolated and treated with interleukin-1 beta (IL-1β) to mimic OA in vitro. High-throughput RNA sequencing was performed to identify differentially expressed circRNAs, miRNAs and mRNAs between IL and 1β-treated chondrocytes and normal chondrocytes. The expression of circATRNL1, miR-153-3p and KLF5 was measured using quantitative real-time polymerase chain reaction (qRT-PCR). For functional analyses, cell apoptosis was assessed using a flow cytometry assay. Extracellular matrix (ECM) degradation was monitored by measuring the levels of ECM-associated proteins by Western blot. The potential target miRNAs of circATRNL1 were screened by bioinformatics analysis and verified by dual-luciferase reporter assay.
Results:
The expression of circATRNL1 was decreased in IL-1β-treated chondrocytes. CircATRNL1 overexpression ameliorated cell apoptosis and ECM degradation, which were promoted by IL-1β treatment. Mechanistic analysis revealed that circATRNL1 directly targeted miR-153-3p and that miR-153-3p could reverse the inhibitory effects of circATRNL1 overexpression on inflammatory responses, cell apoptosis and ECM degradation. KLF5 is a target of miR-153-3p.
Conclusion:
Taken together, the results in this study suggested that circATRNL1 might ameliorate the development and progression of OA through regulating miR-153-3p/KLF5 axis. Our study increased the understanding of circRNAs as therapeutic targets in the treatment of OA.
Insights
Circular RNA ATRNL1 (circATRNL1) protects against osteoarthritis by inhibiting chondrocyte apoptosis and extracellular matrix degradation via the miR-153-3p/KLF5 pathway. This study highlights circRNAs as potential therapeutic targets for osteoarthritis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Osteoarthritis (OA) involves chondrocyte injury, with circular RNAs (circRNAs) implicated in its pathogenesis.
- This study investigates the role of circATRNL1 in osteoarthritis pathology in vitro.
Purpose of the Study:
- To determine the potential role of circATRNL1 in osteoarthritis (OA) pathology in vitro.
- To elucidate the molecular mechanisms underlying circATRNL1's function in OA.
Main Methods:
- Human chondrocytes were treated with IL-1β to simulate OA in vitro.
- RNA sequencing identified differentially expressed circRNAs, miRNAs, and mRNAs.
- Quantitative real-time PCR, flow cytometry, and Western blot assays were used for expression analysis and functional assessments.
Main Results:
- CircATRNL1 expression was reduced in IL-1β-treated chondrocytes.
- Overexpression of circATRNL1 reduced chondrocyte apoptosis and extracellular matrix (ECM) degradation.
- CircATRNL1 directly targets miR-153-3p, which in turn regulates KLF5, mediating the observed effects.
Conclusions:
- CircATRNL1 ameliorates OA development by regulating the miR-153-3p/KLF5 axis.
- This research enhances understanding of circRNAs as potential therapeutic targets for osteoarthritis treatment.
Related Concept Videos
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
MicroRNAs
MicroRNAs
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

